Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2021-09-24 20:54:55 UTC |
---|
Update Date | 2021-09-24 20:54:55 UTC |
---|
HMDB ID | HMDB0304887 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Encorafenib |
---|
Description | Encorafenib belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. Encorafenib is a drug which is used in combination with [binimetinib] in metastatic melanoma with a braf v600e or v600k mutation, as detected by an fda-approved test [l3335]. Based on a literature review very few articles have been published on Encorafenib. |
---|
Structure | COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1 |
---|
Synonyms | Value | Source |
---|
NVP-LGX818 | ChEMBL | LGX-818ENCORAFENIB | ChEMBL | NVP-LGX818-NXA | ChEMBL |
|
---|
Chemical Formula | C22H27ClFN7O4S |
---|
Average Molecular Weight | 540.01 |
---|
Monoisotopic Molecular Weight | 539.1517794 |
---|
IUPAC Name | methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate |
---|
Traditional Name | methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-isopropylpyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC(=O)N[C@@H](C)CNC1=NC=CC(=N1)C1=CN(N=C1C1=CC(Cl)=CC(NS(C)(=O)=O)=C1F)C(C)C |
---|
InChI Identifier | InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1 |
---|
InChI Key | CMJCXYNUCSMDBY-ZDUSSCGKSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Pyrazoles |
---|
Direct Parent | Phenylpyrazoles |
---|
Alternative Parents | |
---|
Substituents | - Phenylpyrazole
- Sulfanilide
- Aminopyrimidine
- Chlorobenzene
- Fluorobenzene
- Halobenzene
- Benzenoid
- Organosulfonic acid amide
- Organic sulfonic acid amide
- Pyrimidine
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Aryl chloride
- Aminosulfonyl compound
- Carbamic acid ester
- Sulfonyl
- Organosulfonic acid or derivatives
- Organic sulfonic acid or derivatives
- Heteroaromatic compound
- Methylcarbamate
- Azacycle
- Organic oxygen compound
- Organochloride
- Organohalogen compound
- Organofluoride
- Amine
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Encorafenib,1TMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4103.1 | Semi standard non polar | 33892256 | Encorafenib,1TMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4001.6 | Standard non polar | 33892256 | Encorafenib,1TMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 6130.7 | Standard polar | 33892256 | Encorafenib,1TMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4132.0 | Semi standard non polar | 33892256 | Encorafenib,1TMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4064.2 | Standard non polar | 33892256 | Encorafenib,1TMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 6025.5 | Standard polar | 33892256 | Encorafenib,1TMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1 | 3989.0 | Semi standard non polar | 33892256 | Encorafenib,1TMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1 | 4011.9 | Standard non polar | 33892256 | Encorafenib,1TMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1 | 6147.9 | Standard polar | 33892256 | Encorafenib,2TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 4015.3 | Semi standard non polar | 33892256 | Encorafenib,2TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 4179.4 | Standard non polar | 33892256 | Encorafenib,2TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 5509.4 | Standard polar | 33892256 | Encorafenib,2TMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 3930.4 | Semi standard non polar | 33892256 | Encorafenib,2TMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4161.7 | Standard non polar | 33892256 | Encorafenib,2TMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 5684.7 | Standard polar | 33892256 | Encorafenib,2TMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 3914.6 | Semi standard non polar | 33892256 | Encorafenib,2TMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 4211.3 | Standard non polar | 33892256 | Encorafenib,2TMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C | 5573.6 | Standard polar | 33892256 | Encorafenib,3TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 3913.5 | Semi standard non polar | 33892256 | Encorafenib,3TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 4345.7 | Standard non polar | 33892256 | Encorafenib,3TMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C)[Si](C)(C)C | 5182.3 | Standard polar | 33892256 | Encorafenib,1TBDMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4287.1 | Semi standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4237.9 | Standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #1 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 6020.4 | Standard polar | 33892256 | Encorafenib,1TBDMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4283.4 | Semi standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4287.7 | Standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #2 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 5918.5 | Standard polar | 33892256 | Encorafenib,1TBDMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1 | 4169.9 | Semi standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1 | 4236.9 | Standard non polar | 33892256 | Encorafenib,1TBDMS,isomer #3 | COC(=O)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1 | 6064.4 | Standard polar | 33892256 | Encorafenib,2TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4333.4 | Semi standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4635.4 | Standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(NS(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5430.8 | Standard polar | 33892256 | Encorafenib,2TBDMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4249.0 | Semi standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4635.6 | Standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #2 | COC(=O)N([C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 5611.0 | Standard polar | 33892256 | Encorafenib,2TBDMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4213.7 | Semi standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 4671.2 | Standard non polar | 33892256 | Encorafenib,2TBDMS,isomer #3 | COC(=O)N[C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C | 5492.3 | Standard polar | 33892256 | Encorafenib,3TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4369.4 | Semi standard non polar | 33892256 | Encorafenib,3TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5043.3 | Standard non polar | 33892256 | Encorafenib,3TBDMS,isomer #1 | COC(=O)N([C@@H](C)CN(C1=NC=CC(C2=CN(C(C)C)N=C2C2=CC(Cl)=CC(N([Si](C)(C)C(C)(C)C)S(C)(=O)=O)=C2F)=N1)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 5176.3 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 10V, Positive-QTOF | splash10-00kg-1101960000-294b6111f39f0027aa80 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 20V, Positive-QTOF | splash10-014i-1202900000-33203f13d78f5ea84168 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 40V, Positive-QTOF | splash10-0gbj-4529600000-984e4a891f3cfdec2b85 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 10V, Negative-QTOF | splash10-0a70-8000290000-b402052b5abd96842521 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 20V, Negative-QTOF | splash10-004i-9000410000-91a972e1956be72f6379 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 40V, Negative-QTOF | splash10-004i-9000000000-85f441a29bc523826a37 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 10V, Positive-QTOF | splash10-0006-0000490000-44859e41739028e80582 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 20V, Positive-QTOF | splash10-00ry-0000920000-2a257f954a3d22bd6de3 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 40V, Positive-QTOF | splash10-00gi-2005900000-4a0031e6257cfff814ea | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 10V, Negative-QTOF | splash10-0019-1000980000-f939ef58c353a4e096dc | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 20V, Negative-QTOF | splash10-0080-1001900000-7650b6a8f6881886a7b7 | 2021-10-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Encorafenib 40V, Negative-QTOF | splash10-0077-9205810000-48e23cae564fa984d021 | 2021-10-22 | Wishart Lab | View Spectrum |
|
---|